C07C 317 - Sulfones; Sulfoxides

Patents for C07C 317 - Sulfones; Sulfoxides (15,874)
12/2001
12/27/2001	US20010056105 Useful as cosmetic for hair and body hygiene, and for treatment of dermatological complaints, with an inflammatory and/or immunoallergic component of rheumatic or respiratory type, cardivascular and opthalmogical disorders
12/25/2001	US6333425 Ionic compounds derived from malononitrile in which anionic charge is delocalized; excellent properties of solubility and dissociation
12/20/2001	WO2001051456A3 Antibacterial agents
12/19/2001	EP1164418A2 Color photothermographic elements comprising blocked developing agents
12/19/2001	EP1164129A1 Industrial process for the production of diphenyl sulfone compounds
12/19/2001	EP1163029A2 Nitrate esters and their use for inducing neuroprotection and cognition enhancement
12/19/2001	EP1162962A1 Alkynyl aryl sulfones
12/19/2001	EP0711270B1 Polymers comprising 4-substituted cyclohexane units
12/19/2001	CN1326996A Non-crystalline tetrafuoro ethylene-hexafuoro propene copolymer
12/19/2001	CN1326929A Process for preparing dimethyl sulfone
12/19/2001	CN1326926A Preparing D-(-)-Su's 1-R-substituted phenyl-2-difluoro acetoamino-3-fluoro-1-propanol from L type substituted phenyl serine ester
12/19/2001	CN1076335C Process for prodn. of 2-(substituted benzyl)-1,3-cyclohexanediones
12/18/2001	US6331652 Process for producing lycopene and intermediate thereof
12/18/2001	US6331563 N-Hydroxy-2-(Alkyl, Aryl, or Heteroaryl, Sulfanyl, Sulfinyl or Sulfonyl)-3-Substituted Alkyl, Aryl or Heteroarylamides as Matrix Metalloproteinase inhibitors
12/18/2001	CA2208585C Benzamidoxime derivative, process for production thereof, and agrohorticultural bactericide
12/13/2001	WO2001094301A2 Factor viia inhibitory (thio)urea derivatives, their preparation and their use
12/13/2001	WO2001094300A1 Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
12/13/2001	WO2001049275A3 Methods and compositions for mitigating pain using nitrate esters
12/13/2001	US20010051657 Malonamic acids and derivatives thereof as thyroid receptor ligands
12/13/2001	CA2345195A1 Color photothermographic elements comprising blocked developing agents
12/12/2001	EP1162194A1 Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use
12/12/2001	EP1161421A1 Inhibitors of protein tyrosine phosphatase
12/12/2001	EP1161415A2 N-cyanomethylamides as protease inhibitors
12/12/2001	EP1161233A2 Lxr modulators
12/12/2001	EP1161232A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
12/12/2001	EP0889936B1 Cationically polymerizable compositions capable of being applied by electrostatic assistance
12/12/2001	EP0860429B1 Diphenyl sulfone crosslinking type compounds and recording materials using them
12/12/2001	EP0854708B1 Lipid alcohols as new immunosuppressive and antiviral drugs
12/12/2001	EP0781126B1 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system
12/12/2001	CN1326439A Phenyl-substituted cyclic enaminones
12/12/2001	CN1326114A Image element containing closed compounds for taking pictures
12/11/2001	US6329421 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
12/11/2001	CA2205033C Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas as 5-lipoxygenase inhibitors
12/06/2001	WO2001092273A2 Benzenedicarboxylic acid derivatives
12/06/2001	DE10027025A1 Clycinamide Clycinamide
12/06/2001	DE10027024A1 Carbaminsäureester Carbamic
12/05/2001	EP1159278A2 Inhibitors of aspartyl protease
12/05/2001	EP1159262A1 Tyrosine alkoxyguanidines as integrin inhibitors
12/05/2001	EP1159260A1 Novel compounds and compositions as protease inhibitors
12/05/2001	EP0828724B1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors
12/05/2001	CN1325380A Benzene derivatives and medical use thereof
12/05/2001	CN1075807C Iminooxymethylene anilides, process and intermediate products for preparing the same and pesticides containing the same
12/04/2001	US6326519 Diallylic sulfides and processes for preparing the same
12/04/2001	US6326398 Oxamic acids and derivatives as thyroid receptor ligands
11/2001
11/29/2001	WO2001090100A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/29/2001	US20010046975 Fungicides for the control of take-all disease of plants
11/29/2001	CA2410294A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/28/2001	EP1158358A2 Imaging element containing a blocked photographically useful compound
11/28/2001	EP1157006A2 Phenyl- and pyridinyl derivatives as neurokinin 1 antagonists
11/28/2001	EP1157002A1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy
11/28/2001	EP1157001A1 Oxamic acids and derivatives as thyroid receptor ligands
11/28/2001	CN1324352A 2-phenylpyran-4-one derivatives
11/28/2001	CN1324345A Compounds comprising polyene chain structure and processes for preparing the same
11/28/2001	CN1075490C O-benzyl oxime ether derivatives and their use in crop production compositions
11/27/2001	US6323229 Compounds are useful psychotherapeutics and are potent agonists and/or antagonists of the serotonin 1a (5-ht 1a) and/or serotonin 1d (5-ht 1d) for treatment of hypertension, depression, generalized anxiety disorder
11/27/2001	CA2021329C Di-aromatic esters, process for their preparation and use in human or veterinary medicine and as cosmetic compositions
11/22/2001	WO2001087840A1 Propanoic acid derivatives as integrin receptor antagonists
11/22/2001	WO2001087830A2 Substituted thioacetamides
11/22/2001	WO2001087829A1 Bisacylguanidine
11/22/2001	DE10024319A1 New bis-acylguanidine compounds are subtype-1 cellular sodium ion-proton antiporter inhibitors useful e.g. for treating arrhythmia, angina pectoris, infarction and insulin-independent diabetes mellitus
11/22/2001	CA2409116A1 Substituted thioacetamides
11/21/2001	EP1155011A1 Di- and tripeptide nitrile derivatives as inhibitors of cathepsin l and cathepsin s
11/21/2001	EP1154992A1 N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of c-proteinase and for treating or preventing disorders related to unregulated collagen production
11/21/2001	EP1154987A1 Phenylalaninol derivatives
11/21/2001	EP1154984A1 Inhibitors for uptake of serotonine, dopamine or norepinephrine
11/21/2001	CN1323292A Benzoylcyclohexandiones, method for the production and use thereof as herbicides and plant growth regulators
11/21/2001	CN1323289A Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
11/21/2001	CN1075058C Process for producing aromatic sulfonyl halides
11/20/2001	US6320050 2-substituted phenyl-3-cycloalkyl substituted n-heteroaromatic propionamides; used to increase insulin secretion in the treatment of type ii diabetes.
11/20/2001	US6319956 N1, n4-bis(cyclopropylmethylamino)trialkylenetetramines that may be toluenesulfonated.
11/20/2001	US6319946 Inhibitors of aspartyl protease
11/20/2001	US6319925 O-benzyl oxime ether derivatives and their use in crop protection compositions
11/20/2001	US6319428 Perfluorinated amide salts and their uses as ionic conducting materials
11/20/2001	CA2007786C Indenyl hydroxamic acids and hydroxy ureas as inhibitors of 5-lipoxygenase
11/15/2001	WO2001085706A1 Substituted phenylacetamides and their use as glucokinase activators
11/15/2001	WO2001085680A2 Sulfonyl aryl or heteroaryl hydroxamic acid compounds
11/15/2001	WO2001008672A3 Glucamine compounds for treating hepatitis virus infections
11/15/2001	US20010041726 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/15/2001	DE10023405A1 Preparation of N-(4,5-bis-(alkanesulfonyl)-2-alkyl-benzoyl)-guanidine salt used as sodium ion-proton antiporter inhibitor, by alkylsulfonylation of 4-substituted benzoate ester, reaction with guanidine and salification
11/14/2001	CN1322196A Naphthalenecaarboxamides as tachykinin receptor antagonists
11/13/2001	US6316670 Photothermography, thermal recording media; storage and stock stability; antifogging; heat and radiation resistance; medical diagnosis; thermosensitivity
11/13/2001	US6316636 Synthesis of fluorocarbon compounds
11/13/2001	US6316503 For therapy of disease states associated with cholesterol metabolism such as atherosclerosis and hypercholesterolemia
11/13/2001	US6316396 Amphiphilic compounds with at least two hydrophilic and at least two hydrophobic groups based on di-, oligo- or polyolethers
11/08/2001	WO2001083434A2 P-(sulfonyl)-aryl and heteroaryls amines
11/08/2001	WO2001083433A1 Bifunctional inhibitors of malarial proteases and uses thereof
11/08/2001	WO2001083432A2 Process for the reduction of cyano-substituted sulfones to aminoalkylene-substituted sulfones
11/08/2001	WO2001083421A1 Process for the preparation of 2-halobenzoic acids
11/08/2001	US20010039351 Reacting 7-(2-aminoethyl)-4-hydroxy-1,3-benzothiazole-2-one or its salt with 2-(3-etheneylsulfonylpropoxy)ethyl benzene in presence of solvent and tertiary amine base
11/08/2001	US20010039344 Antidiabetic agents
11/08/2001	CA2409139A1 Process for the reduction of cyano-substituted sulfones to aminoalkylene-substituted sulfones
11/08/2001	CA2405832A1 P-(sulfonyl)aryl and heteroaryls
11/07/2001	EP1150950A2 Anthranilic acid derivatives
11/07/2001	EP1150944A1 N2-phenylamidine derivatives
11/07/2001	CN1321146A Process for producing alkylsulfonylbenzaldehyde
11/06/2001	US6313351 Process for producing alicyclic monoketones and process for producing alicyclic diketones
11/06/2001	US6313150 α-substituted phenylacetic acid derivative, its production and agricultural fungicide containing it
11/06/2001	US6313146 Calcium receptor-active molecules
11/06/2001	US6313122 As inhibitors of factor xa and are used as anticoagulants in mammals
11/06/2001	CA2193178C Matrix metalloprotease inhibitors

1 ... 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 ... 159